Overview

Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)

Status:
Completed

Trial end date:
2011-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to estimate the effect of filibuvir on the pharmacokinetics of ethinyloestradiol [EE] and levonorgestrel [LN], to assess the safety and tolerability of 600 mg BID of filibuvir in healthy women and to investigate the pharmacokinetics of 600 mg BID of filibuvir in healthy women.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Contraceptive Agents
Contraceptives, Oral
Estradiol
Ethinyl Estradiol
Ethinyl estradiol, levonorgestrel drug combination